Navigation Links
Radiation Oncology Experts from 16 Countries Attend Technical University of Munich's International Conference on TomoTherapy
Date:10/29/2008

TomoTherapy Incorporated (NASDAQ: TOMO) announced today that Technical University of Munich, Germany, recently welcomed 175 radiation oncology experts from 16 countries to the ‘International Conference on the Clinical Use of TomoTherapy’. The two-day event featured 35 technical talks from doctors and physicists. Presentations covered the multiple cancer types clinicians are treating with CT-guided, helical TomoTherapySM and treatment protocols that show promise in gaining improved outcomes for patients.

MADISON, Wis. (Business Wire EON) October 29, 2008 -- "We were extremely pleased to host this exciting scientific meeting to explore the clinical use of TomoTherapy," said Prof. Michael Molls, M.D., chairman of Radiation Oncology, Klinikum Rechts der Isar, Technical University of Munich. "Our clinic has used TomoTherapy for the last 2 years in a project funded by the German Oncology research foundation. This new technology, which combines CT imaging with a linear accelerator in one device, allows us to treat patients with a higher accuracy and to better shape dose distributions to target tumour volumes."

Notable conference presentations included:

  • Patrick Kupelian, director of Clinical Research for Radiation Oncology at MD Anderson Cancer Center Orlando, Florida on TomoTherapy for prostate cancer; and Prof. Guy Storme, M.D., Ph.D., director of the Oncologic Center at UZ Brussel, Brussels, Belgium on the use of TomoTherapy for the treatment of head and neck tumours; "The gathered international clinicians enjoyed presentations covering many of the clinical possibilities for TomoTherapy," said Dr. Kupelian. "Evidenced in many presentations is the need for volumetric daily image guidance such as that provided on the TomoTherapy HiArt treatment system. It is important to continue such meetings to allow sharing of experience with the goal to deliver improved outcomes for our patients."

Prof. Storme added, "Meetings like this help us understand the range of possibilities with a platform like TomoTherapy and highlight the need for clinical Phase 3 studies to make most use of this technology which seems to have a beneficial effect for patients in reducing side effects."

Thomas 'Rock' Mackie, Ph.D., TomoTherapy co-founder and chairman of the board, discussed the experience of taking TomoTherapy from concept to clinical routine and thanked Technical University of Munich for organizing a successful conference.

"I am excited to see so many respected members of the international radiation oncology community gather to present the wonderful work they are doing with TomoTherapy," said Mackie. "It is a great opportunity for us to see the way the potential of this platform is being explored and how future developments will extend the possibilities."

About TomoTherapy Incorporated

TomoTherapy Incorporated has developed, markets and sells the TomoTherapy HiArt treatment system, an advanced radiation therapy system for the treatment of a wide variety of cancers. The HiArt treatment system combines integrated CT imaging with conformal radiation therapy to deliver sophisticated radiation treatments with speed and precision while reducing radiation exposure to surrounding healthy tissue. The company's stock is traded on the NASDAQ Global Select Market under the symbol TOMO. To learn more about TomoTherapy, please visit TomoTherapy.com.

2008 TomoTherapy Incorporated. All rights reserved. TomoTherapy, the TomoTherapy logo and HiArt are among trademarks, service marks or registered trademarks of TomoTherapy Incorporated.

Read the full story at http://www.prweb.com/releases/technical_university/radiation_oncology/prweb1546454.htm


'/>"/>
Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Grupo IMO Hosts Symposium on Use of TomoTherapy for Stereotactic Radiosurgery and Stereotactic Body Radiation Procedures : Experts Detail HiArt Platform Advantages for Treatment of Brain, Lung, Pancreatic and Metastatic Cancers
2. OHSU Cancer Institute researcher: radiation, immunotherapy gives greater effectiveness
3. Cancer patients who receive neoadjuvant therapy followed by mastectomy may not need radiation
4. OHSU Cancer Institute researchers study breathing during radiation
5. Digirad Corporation Receives FDA 510(k) Clearance for nSPEED(R) Reconstruction Software for Improved Image Quality in Less Time With Less Radiation
6. Whole brain radiation increases risk of learning and memory problems in cancer patients
7. Radiation Oncology Services of America, Inc. Announces Formation of Scientific Advisory Board
8. Radiation Oncology Institute Campaign Raises $3 Million
9. Dr. Chad Levitt Joins North Georgia Radiation Oncology Center
10. Drug/radiation combo may help shrink established tumors
11. Grocery Manufacturers Association Strongly Supports U.S. Food & Drug Administration Decision on the Irradiation of Fresh Produce for Foodborne Pathogen Control
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
 Radiation Oncology Experts from 16 Countries Attend Technical University of Munich's International Conference on TomoTherapy 
(Date:6/25/2016)... ... June 25, 2016 , ... The temporary closing of Bruton Memorial Library on June 21 ... brings up a new, often overlooked aspect of head lice: the parasite’s ability to live ... not a common occurrence, but a necessary one in the event that lice have simply ...
(Date:6/25/2016)... ... , ... On Friday, June 10, Van Mitchell, Secretary of the Maryland Department ... in recognition of their exemplary accomplishments in worksite health promotion. , The Wellness at ... Wellness Symposium at the BWI Marriott in Linthicum Heights. iHire was one of 42 ...
(Date:6/24/2016)... PASADENA, CA (PRWEB) , ... June 24, 2016 , ... Marcy was in a crisis. ... he would lash out at his family verbally and physically. , “When something upset him, ... table, he would use it. He would throw rocks at my other children and say ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway ... call for a minimum wage raise to $12 an hour by 2020 and then adjusting ... restore the lost value of the minimum wage, assure the wage floor does not erode ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... actively feeding the Frederick area economy by obtaining investment capital for emerging technology ... past 2½ years that have already resulted in more than a million dollars ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016 The Academy of ... recommendations that would allow biopharmaceutical companies to ... entities that make formulary and coverage decisions, a move ... of new medicines. The recommendations address restrictions ... appear on the drug label, a prohibition that hinders ...
(Date:6/24/2016)...   Pulmatrix, Inc ., (NASDAQ: PULM ... announced today that it was added to the Russell ... comprehensive set of U.S. and global equity indexes on ... milestone for Pulmatrix," said Chief Executive Officer Robert ... progress in developing drugs for crucial unmet medical needs, ...
(Date:6/23/2016)... Any dentist who has made an implant supported ... Many of them do not even offer this as a ... laboratory costs involved. And those who ARE able to offer ... high cost that the majority of today,s patients would not ... Zadeh , founder of Dental Evolutions Inc. and inventor of ...
Breaking Medicine Technology: